|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Option (Rigth to Buy) | $ 39.92 | 03/12/2010 | M | 7,500 | 04/28/2007(8) | 04/28/2011 | Common Stock | 7,500 | $ 0 | 0 | D | ||||
Stock Option (Rigth to Buy) | $ 31.77 | 03/12/2010 | M | 7,500 | 07/31/2007(8) | 07/31/2011 | Common Stock | 7,500 | $ 0 | 0 | D | ||||
Stock Option (Rigth to Buy) | $ 34.99 | 03/12/2010 | M | 100,000 | 10/02/2007(8) | 10/02/2011 | Common Stock | 100,000 | $ 0 | 0 | D | ||||
Stock Option (Rigth to Buy) | $ 39.86 | 03/12/2010 | M | 18,125 | 10/01/2008(8) | 10/01/2012 | Common Stock | 18,125 | $ 0 | 4,375 | D | ||||
Stock Option (Rigth to Buy) | $ 32.75 | 03/12/2010 | M | 11,460 | 04/30/2009(8) | 04/30/2013 | Common Stock | 11,460 | $ 0 | 7,290 | D | ||||
Stock Option (Rigth to Buy) | $ 26.64 | 03/12/2010 | M | 9,897 | 07/31/2009(8) | 07/31/2013 | Common Stock | 9,897 | $ 0 | 8,853 | D | ||||
Stock Option (Rigth to Buy) | $ 20.09 | 03/12/2010 | M | 14,170 | 03/02/2010(8) | 03/02/2014 | Common Stock | 14,170 | $ 0 | 28,330 | D | ||||
Stock Option (Right to Buy) | $ 23.46 | 03/12/2010 | M | 26,497 | 08/15/2006(9) | 08/15/2010 | Common Stock | 26,497 | $ 0 | 0 | D | ||||
Stock Option (Right to Buy) | $ 2.52 | 03/12/2010 | M | 37,909 | 08/28/2005(10) | 01/11/2015 | Common Stock | 37,909 | $ 0 | 0 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Wasson Wesley R C/O CITRIX SYSTEMS, INC. 851 WEST CYPRESS CREEK ROAD FORT LAUDERDALE, FL 33309 |
SVP & Chief Marketing Officer |
/s/Antonio Gomes, Attorney-in-Fact for Wesley R. Wasson | 03/16/2010 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | The sales reported in this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. |
(2) | The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold in this tranche on this date. The actual sale prices per share range from $46.84 to $47.33. |
(3) | The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold in this tranche on this date. The actual sale prices per share range from $46.85 to $47.30. |
(4) | The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold in this tranche on this date. The actual sale prices per share range from $46.83 to $47.33. |
(5) | The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold in this tranche on this date. The actual sale prices per share range from $46.83 to $47.31. |
(6) | The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold in this tranche on this date. The actual sale prices per share range from $46.84 to $47.31. |
(7) | The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold in this tranche on this date. The actual sale prices per share range from $46.85 to $47.31. |
(8) | Stock Options vest at a rate 1/3 of the shares underlying the stock option one year from the date of grant and at a rate of 1/36 monthly thereafter. |
(9) | Stock Options vested as to 1/2 of the shares underlying the stock option on August 15, 2006 and vested as to the remaining 1/2 on August 15, 2007. |
(10) | Stock Options vest monthly over the course of 41 months from the date of grant. |